True 'dat. :)

0.63. That's still the resistance.

We need to hold at 0.63 or ABOVE today.

No worries. Best of luck to you and to all of us!

Go ONCS!

You may very well be successful with your approach. But there is risk.

With so many catalysts due very soon, a run-up is possible in advance of them. Find yourself out of the stock when PRs are issued means you'll then need to chase, and you will have already lost money.

Far easier just to wait for the catalysts to hit and enjoy the run-up rather than risking missing it for a few pennies. Ask Furbush about that. Just my .02.

ONCS is also working on identifying "biomarkers" which will help identify which patients will respond best.

So, they are working both ends of the desired solution, not just turning non-responders into responders.

Thanks for doing that, Jeff, much appreciated.

More than minor changes are needed in my opinion in order to get it above college intern status. It needs to be completely redesigned. It looks stale and uninviting.

Interestingly enough, I believe he "recommended" on LinkedIn the work of the person who originally put it together.

Has anyone tweeted Punit about the website?

He has to be aware that the website is substandard and not very eye catching. Look at INO's website and see the difference between the two.

The choice of orange as a primary color isn't too good and the font selection makes reading hard. It turns me away just looking at it!

"ONCS isn't reinventing the wheel, they are just making it work better."

Funny, I used the BASF product analogy from the 1990s here a few weeks ago:

My best "guess" is $200-300M market cap by EOY and somewhere "north" of $300M by end of Q1 2015.

That's being conservative but it's still quite a bit higher than where we are now. I hope I'm wrong and that we're way higher, but I'd rather be pleasantly surprised rather than disappointed.

Agreed. To me, the valuation is based on those factors but also WHEN the buyout occurs is usually the most telling. Buy too soon and you don't have the empirical results you need. Buy too late and it gets too expensive. Lots of variables involved.

One thing is certain. ONCS will be worth a LOT more a year from now. Multiples more. Count on it.

Notwithstanding Dr. Pierce's relationship with Merck, I found the hiring of one of their senior legal personnel to become our general counsel to be "extremely odd."

Maybe that person is doing a bunch of due diligence on ONCS' IP to ensure that everything is "in order" before a buyout offer is tendered sometime later in 2015? Who knows.

IF a buyout occurs before any P3 trials have been completed I'd expect it to be for a little less than $1B. Right now I'd say we're worth $200-300M. Still, in any scenario, that's a huge premium from the share price today.

Whatever the case may be, the future is bright for ONCS and cancer patients around the world. At the end of the day, that is what really matters.

It's still a "wall" until we break through it. :)

OK, let's play smash-mouth football next week!

Breakthrough!

0.63 will finally be taken out next week. (At least I hope.)

Happy Black Friday shopping and everyone have a great weekend!

We need to break through it first. :)

0.63 has been a tough wall to crack. Hopefully with new investors coming on board and with more milestones to be reached shortly this barrier will be a thing of the past.

Go ONCS!

I'll raise you a dime to 0.70. :)

IF they do that I'm prepared with some dry powder to spend, depending on how far they take it down. :)

That's what we're up against.

For now.

Agreed. What affect, if any, will it have on our monthly burn rate?

You'll see it pretty clearly during this short chart video:

http://claytrader.com/stock_chart/ONCS/

Mind you, this is just a technical analysis. It has nothing to do with PPS movement based on news.

It's got to break through it. :)

0.63 has been a resistance level for a pretty long time.

I hope not, but we may need another PR to break through it.

Just another analyst upgrade would do it. Can you say "Maxim?" :)

0.63 is the WALL!

Once we break through the 0.70s will come pretty easily, IMHO.

We may need the next big PR to do it, though. Technicals may not be enough.

Go ONCS!

Indeed. Maxim will very likely "reiterate" their buy rating on ONCS and perhaps give a new (higher) price target.

Bring it on!

I've been pumping them relentlessly to my friends the last couple of months. Got one friend to invest early last week.

LMAO! You put a smile on my grin tonight, Fur.

D'oh. I must be drinking too much. Or not the right stuff. LOL.

I could have sworn I saw this:

November 18, 2014 10:42 AM

Instead of this:

November 18, 2013 10:42 AM

How did this get into the article?

"OncoSec is small; it has a market cap of $25.11 million. YTD the stock is up almost 25% closing on Thursday, November 14th at $0.274."

Let's tear down that wall at 0.60!

Let's do this!

$4 Price target (up from $2) in that Zacks article.

Nice.

"How to get it out there?"

Just a short article at SA will do just fine...

Fur--come to us, please! :)

Fur: Time for a short article!

We need to get the word out about the SIGNIFICANCE of this "collaboration" with MERCK. The article need not be long, but just to get this single point across.

ONCS and Punit were constrained by Merck's PR guidelines, but I do not believe that you will be. Perfect opportunity for a short article to boost the PPS and give it some staying power.

What say ye?

Can someone communicate this to Dhillon?

Where is Acorn when we need them? I would think they'd be providing some oversight to the PRs if not even creating them?

Where is Acorn when we need them?

I thought they were in charge of PR for the company?

Great news, no doubt, but also a bit disappointing in the same vein.

Not enough emphasis on Merck in the PR. No money up front. It will be interesting to see how the market digests this.

How long will it take to complete this trial?

Let's repeat it in unison! :)

Let's hope that 2015 is for ONCS what 2013 was for INO!

What about the MCC data?

Do you believe that they know it NOW?

Does ONCS management "know" all of the data NOW?

If not, what items are indeterminate at this time?

Agreed. I may dump my RXII shares and buy still more ONCS.

But I may wait and see if we break below 0.50 before doing so.

Couldn't resist.

Sold some INO and added 20,000 more shares of ONCS @ 0.515 just now.